JAMJOOM PHARMA - Analyst Estimates
Jamjoom Pharma seen to post profit growth in Q4 2023
Argaam Special 20/02/2024
GIB Capital previews Q4 2023 earnings
Argaam Special 10/01/2024
How did analysts view TASI performance, top picks for 2024?
Argaam Special 09/01/2024
Al Rajhi Capital issues Q4 2023 earnings forecasts
Argaam Special 08/01/2024
United Securities previews Q4 2023 earnings for Saudi firms
Argaam Special 07/01/2024
Al Rajhi Capital expects TASI to hit 12,647 pts, names top picks
Argaam 07/01/2024
How did analysts view Jamjoom Pharma’s Q3 financials?
Argaam Special 05/12/2023
GIB Capital sets rating for Jamjoom Pharma
Argaam 03/12/2023
Al Rajhi Capital says Saudi pharmaceuticals sector poised for growth; sets recommendations, TP
Argaam 23/11/2023
Al Rajhi Capital issues Q3 profit forecasts for Saudi-listed companies
Argaam Special 05/10/2023
Al Rajhi Capital issues Q2 earnings estimates
ِArgaam 10/07/2023
Al Rajhi Capital begins coverage of Saudi pharma sector, assigns ratings
Argaam 05/07/2023
GIB Capital initiates coverage on Jamjoom Pharma
ِArgaam 20/06/2023